Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Genpact Ltd (NYSE: G) closed at $44.06 down -0.34% from its previous closing price of $44.21. In other words, the price has decreased by -$0.34 from its previous closing price. On the day, 0.85 million shares were traded. G stock price reached its highest trading level at $44.44 during the session, while it also had its lowest trading level at $44.05.
Ratios:
For a deeper understanding of Genpact Ltd’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.70. For the most recent quarter (mrq), Quick Ratio is recorded 1.51 and its Current Ratio is at 1.51. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.39.
Upgrades & Downgrades
In the most recent recommendation for this company, Citigroup on October 23, 2025, initiated with a Neutral rating and assigned the stock a target price of $43.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 14 ’25 when Weiner Michael Hal sold 13,365 shares for $44.84 per share. The transaction valued at 599,287 led to the insider holds 148,026 shares of the business.
MICHAEL H WEINER bought 13,365 shares of G for $599,315 on Nov 14 ’25. On Nov 13 ’25, another insider, White Heather, who serves as the SVP & Chief Legal Officer of the company, sold 45,703 shares for $45.74 each. As a result, the insider received 2,090,455 and left with 50,569 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, G now has a Market Capitalization of 7678340096 and an Enterprise Value of 8280691712. As of this moment, Genpact’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.20, and their Forward P/E ratio for the next fiscal year is 11.19. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.43. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.52 while its Price-to-Book (P/B) ratio in mrq is 2.99. Its current Enterprise Value per Revenue stands at 1.653 whereas that against EBITDA is 9.838.
Stock Price History:
The Beta on a monthly basis for G is 0.75, which has changed by -0.04817456 over the last 52 weeks, in comparison to a change of 0.1326145 over the same period for the S&P500. Over the past 52 weeks, G has reached a high of $56.76, while it has fallen to a 52-week low of $37.49. The 50-Day Moving Average of the stock is 6.46%, while the 200-Day Moving Average is calculated to be -2.19%.
Shares Statistics:
For the past three months, G has traded an average of 2.02M shares per day and 2029860 over the past ten days. A total of 172.41M shares are outstanding, with a floating share count of 157.99M. Insiders hold about 8.37% of the company’s shares, while institutions hold 96.87% stake in the company. Shares short for G as of 1763078400 were 6882328 with a Short Ratio of 3.41, compared to 1760486400 on 7734359. Therefore, it implies a Short% of Shares Outstanding of 6882328 and a Short% of Float of 4.5700002.
Dividends & Splits
According to the company, the forward annual dividend rate for G is 0.66, from 0.663 in the trailing year. Against a Trailing Annual Dividend Yield of 0.014996607. The stock’s 5-year Average Dividend Yield is 1.25.
Earnings Estimates
A detailed examination of Genpact Ltd (G) is currently in progress, with 10.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.91, with high estimates of $0.95 and low estimates of $0.89.
Analysts are recommending an EPS of between $3.64 and $3.6 for the fiscal current year, implying an average EPS of $3.62. EPS for the following year is $3.94, with 11.0 analysts recommending between $4.01 and $3.88.
Revenue Estimates
A total of 8 analysts believe the company’s revenue will be $1.31B this quarter.It ranges from a high estimate of $1.32B to a low estimate of $1.3B. As of . The current estimate, Genpact Ltd’s year-ago sales were $1.25BFor the next quarter, 8 analysts are estimating revenue of $1.29B. There is a high estimate of $1.31B for the next quarter, whereas the lowest estimate is $1.27B.
A total of 11 analysts have provided revenue estimates for G’s current fiscal year. The highest revenue estimate was $5.08B, while the lowest revenue estimate was $5.07B, resulting in an average revenue estimate of $5.07B. In the same quarter a year ago, actual revenue was $4.77BBased on 11 analysts’ estimates, the company’s revenue will be $5.42B in the next fiscal year. The high estimate is $5.48B and the low estimate is $5.37B.
